Fortive has delivered a solid multi year share price run, and with cash flows in focus the question now is whether the current valuation lines up with what the business is actually generating. Recent news around earnings, cash deployment and guidance has pushed the conversation toward what investors are paying today for those future streams of cash.
The issue now is whether Fortive's current share price is justified by the cash flows implied by a Discounted Cash Flow (DCF) view of the business.
If you want to stress test this same cash flow question beyond Fortive, you can compare it with a wider set of 26 high quality undervalued stocks.
The Discounted Cash Flow (DCF) model here looks at the cash Fortive can generate for shareholders and then discounts it back to today. Latest twelve month free cash flow sits at about $953 million, and the projections assume that this pool of cash continues to grow at a measured pace rather than through sharp jumps.
On that basis, the DCF estimate lines up broadly with where the stock currently trades at $64.11. Because Fortive recently reported strong Q3 2026 results and lifted full year EPS guidance, this closer match between price and projected cash generation suggests the recent optimism is largely reflected in the share price already. Find out what Fortive could be worth using our Discounted Cash Flow (DCF) estimate.
Fortive's valuation puzzle only really comes into focus once the market's stories about its future cash generation are put on the table. Narratives on Simply Wall St's Community page link the current share price to clear assumptions about growth, profitability and earnings power, and each one ties a specific fair value to a particular mix of potential catalysts and risks so you can track over time which version of Fortive's story is actually unfolding.
Community views on Fortive split between those who see more upside in the recurring revenue story and those who think the current price already reflects most of that potential.
Bull case: 11% undervalued
"ASP’s FDA clearance for a 50 pound expanded load capacity on STERRAD sterilizers creates room for higher throughput on equipment already in hospitals..."
Discover why this Narrative puts Fortive at 11% undervalued.
Bear case: roughly fairly valued
"Product mix continues to shift toward lower margin offerings faster than Fortive can offset with pricing and cost efficiencies..."
Explore why this Narrative puts Fortive at roughly fairly valued.
Before you lean too hard on the cash flow math for Fortive, it is worth weighing a separate set of caution flags that the broader research process has already picked up. Take a closer look at 1 warning sign before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com